Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer

被引：0
作者：
Andreas Ihrig
Pascal Marino Pernt
Stefanie Zschäbitz
Johannes Huber
Hans-Christoph Friederich
Till J. Bugaj
Imad Maatouk
机构：
[1] University Hospital Heidelberg,Division of Psycho
[2] National Centre for Tumor Diseases (NCT),Oncology, Department of General Internal Medicine and Psychosomatics
[3] University Hospital Heidelberg,Department of Medical Oncology
[4] Philipps-University Marburg,Department of Urology
[5] Julius-Maximilian University Würzburg,Section of Psychosomatic Medicine, Psychotherapy and Psycho
来源：
International Urology and Nephrology | 2023年 / 55卷
关键词：
Metastatic prostate cancer; Hormonal agents; Androgen deprivation therapy; Neurocognitive effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2733 / 2739
页数：6
相关论文
共 50 条
  • [31] Androgen and prostate cancer: the role of primary androgen deprivation therapy in localized prostate cancer
    Namiki, Mikio
    Kitagawa, Yasuhide
    Mizokami, Atsushi
    Koh, Eitetsu
    JOURNAL OF MENS HEALTH, 2008, 5 (04) : 333 - 341
  • [32] Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial
    Boeve, Liselotte M. S.
    Hulshof, Maarten C. C. M.
    Vis, Andre N.
    Zwinderman, Aeilko H.
    Twisk, Jos W. R.
    Witjes, Wim P. J.
    Delaere, Karl P. J.
    van Moorselaar, R. Jeroen A.
    Verhagen, Paul C. M. S.
    van Andel, George
    EUROPEAN UROLOGY, 2019, 75 (03) : 410 - 418
  • [33] Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer
    Sentana-Lledo, Daniel
    Morgans, Alicia K.
    CURRENT ONCOLOGY REPORTS, 2024, 26 (03) : 299 - 306
  • [34] Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
    Corona, Giovanni
    Gacci, Mauro
    Baldi, Elisabetta
    Mancina, Rosa
    Forti, Gianni
    Maggi, Mario
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 (03) : 887 - 902
  • [35] Metabolic changes in patients with prostate cancer during androgen deprivation therapy
    Mitsuzuka, Koji
    Arai, Yoichi
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (01) : 45 - 53
  • [36] Androgen-Deprivation Therapy and the Risk of Stroke in Patients With Prostate Cancer
    Azoulay, Laurent
    Yin, Hui
    Benayoun, Serge
    Renoux, Christel
    Boivin, Jean-Francois
    Suissa, Samy
    EUROPEAN UROLOGY, 2011, 60 (06) : 1244 - 1250
  • [37] Race and Time to Receipt of Androgen Deprivation Therapy Among Men With Metastatic Prostate Cancer
    Cobran, Ewan K.
    Young, Henry N.
    Chen, Ronald C.
    Chen, Xianyan
    Reeves, Jaxk
    Godley, Paul A.
    Shah, Surbhi
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2019, 111 (03) : 246 - 255
  • [38] Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer
    Sahin, Ali F.
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (02): : 178 - 180
  • [39] Current Approach to Androgen Deprivation Therapy in Patients With Advanced Prostate Cancer
    Heidenreich, Axel
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (11) : 776 - 781
  • [40] Osteoporosis Management in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
    Ellen F. T. Yee
    Robert E. White
    Glen H. Murata
    Christine Handanos
    Richard M. Hoffman
    Journal of General Internal Medicine, 2007, 22 : 1305 - 1310
12345